Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells

Biochemical and Biophysical Research Communications

Volumn 337, Issue 4, 2005, Pages 1084-1091

  Jiang, He ^a   Xiao, Fei Wang ^a   Fang, Liang ^a   Tang, Chaoshu ^a   Zhu, Yi ^a   Wang, Xian ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Aldose reductase; Homocysteine; Reactive oxygen species; Surfactant protein B

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ALRESTATIN; CATALASE; HOMOCYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RAF PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SURFACTANT PROTEIN B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

ALDEHYDE REDUCTASE; ALVEOLAR PROCESS; CELL LINE, TUMOR; ENZYME INDUCTION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HOMOCYSTEINE; HUMANS; PROTEOME; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 27144446156     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.160     Document Type: Article

References (29)

1. S.S. Kang, P.W. Wong, and M.R. Malinow Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease Annu. Rev. Nutr. 12 1992 279 298
2. M. Medina, J.L. Urdiales, and M.I. Amores-Sanchez Roles of homocysteine in cell metabolism: old and new functions Eur. J. Biochem. 268 2001 3871 3882
3. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, and I. Graham Hyperhomocysteinemia: an independent risk factor for vascular disease N. Engl. J. Med. 324 1991 1149 1155
4. C.J. Boushey, S.A.A. Beresford, G.S. Omenn, and A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1057
5. M.C. Audelin, and J. Genest Jr. Homocysteine and cardiovascular disease in diabetes mellitus Atherosclerosis 159 2001 497 511
6. A.N. Friedman, A.G. Bostom, J. Selhub, A.S. Levey, and I.H. Rosenberg The kidney and homocysteine metabolism J. Am. Soc. Nephrol. 12 2001 2181 2189
7. N.M. van der Put, H.W. van Straaten, F.J. Trijbels, and H.J. Blom Folate, homocysteine and neural tube defects: an overview Exp. Biol. Med. (Maywood) 226 2001 243 270
8. G.H. Werstuck, S.R. Lentz, S. Dayal, G.S. Hossain, S.K. Sood, Y.Y. Shi, J. Zhou, N. Maeda, S.K. Krisans, M.R. Malinow, and R.C. Austin Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways J. Clin. Invest. 107 2001 1263 1273
9. W. Herrmann, and J.P. Knapp Hyperhomocysteinemia: a new risk factor for degenerative diseases Clin. Lab. 48 2002 471 481
10. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. D'Agostino, P.W.F. Wilson, and P.A. Wolf Plasma homocysteine as a risk factor for dementia and alzheimer's disease N. Engl. J. Med. 346 2002 476 483
11. L.L. Wu, and J.T. Wu Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker Clin. Chim. Acta 322 2002 21 28
12. K. Schroecksnadel, B. Frick, B. Wirleitner, C. Winkler, H. Schennach, and D. Fuchs Moderate hyperhomocysteinemia and immune activation Curr. Pharm. Biotechnol. 5 2004 107 118
13. S. Sztenc Hyperhomocysteinemia and pregnancy complications Ginekol. Pol. 75 2004 317 325
14. A. Bhatnagar, and S.K. Srivastava Aldose reductase: congenial and injurious profiles of an enigmatic enzyme Biochem. Med. Metab. Biol. 48 1992 91 121
15. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
16. C. Yabe-Nishimura Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications Pharmacol. Rev. 50 1998 21 33
17. M.B. Burg Molecular basis of osmotic regulation Am. J. Physiol. 268 1995 983 996
18. N. Hotta New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition Nagoya J. Med. Sci. 60 1997 89 100
19. S.E. Spycher, S. Tabataba-Vakili, V.B. O'Donnell, L. Palomba, and A. Azzi Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells FASEB J. 11 1997 181 188
20. N. Nakamura, H. Obayashi, M. Fujii, M. Fukui, K. Yoshimori, M. Ogata, G. Hasegawa, H. Shigeta, Y. Kitagawa, T. Yoshikawa, M. Kondo, M. Ohta, M. Nishimura, T. Nishinaka, and C.Y. Nishimura Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products Free Radic. Biol. Med. 29 2000 17 25
21. J. Ruef, S.Q. Liu, C. Bode, M. Tocchi, S. Srivastava, M.S. Runge, and A. Bhatnagar Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury Arterioscler. Thromb. Vasc. Biol. 20 2000 1745 1752
22. F. Possmayer The role of the surfactant-associated proteins Am. Rev. Respir. Dis. 142 1990 749 752
23. J.C. Clark, S.E. Wert, C.J. Bachurski, M.T. Stahlman, B.R. Stripp, T.E. Weaver, and J.A. Whitsett Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis causing respiratory failure in newborn mice Proc. Natl. Acad. Sci. USA 92 1995 7794 7798
24. J.A. Whitsett, L.M. Nogee, T.E. Weaver, and A.D. Horowitz Human surfactant protein B: structure, function, regulation, and genetic disease Physiol. Rev. 75 1995 749 757
25. T. Gregory, W.J. Longmore, M.A. Moxley, J.A. Whitsett, C.R. Reed, A.A. Fowler, L.D. Hudson, R.J. Maunder, C. Crim, and T.M. Hyers Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome J. Clin. Invest. 88 1991 1976 1981
26. G.S. Pryhuber, C. Bachurski, R. Hirsch, A. Bacon, and J.A. Whitsett Tumor necrosis factor-α decreases surfactant protein B mRNA in murine lung Am. J. Physiol. 270 1996 714 721
27. E.P. Ingenito, R. Mora, M. Cullivan, Y. Marzan, K. Haley, L. Mark, and L.A. Sonna Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury Am. J. Respir. Cell Mol. Biol. 25 2001 35 44
28. L. Chang, J. Xu, F. Yu, J. Zhao, X. Tang, and C. Tang Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats Amino Acids 27 2004 37 48
29. T. Nishinaka, and C. Yabe-Nishimura EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress Free Radic. Biol. Med. 31 2001 205 216